GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » Beneish M-Score

ViroGates A/S (OCSE:VIRO) Beneish M-Score : -4.06 (As of May. 11, 2024)


View and export this data going back to 2018. Start your Free Trial

What is ViroGates A/S Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.06 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for ViroGates A/S's Beneish M-Score or its related term are showing as below:

OCSE:VIRO' s Beneish M-Score Range Over the Past 10 Years
Min: -4.24   Med: -1.6   Max: 0.28
Current: -4.06

During the past 8 years, the highest Beneish M-Score of ViroGates A/S was 0.28. The lowest was -4.24. And the median was -1.60.


ViroGates A/S Beneish M-Score Historical Data

The historical data trend for ViroGates A/S's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates A/S Beneish M-Score Chart

ViroGates A/S Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial -0.68 -2.78 -1.05 -0.49 -3.25

ViroGates A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.79 -4.24 -3.76 -3.25 -4.06

Competitive Comparison of ViroGates A/S's Beneish M-Score

For the Medical Devices subindustry, ViroGates A/S's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ViroGates A/S's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ViroGates A/S's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where ViroGates A/S's Beneish M-Score falls into.



ViroGates A/S Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of ViroGates A/S for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.4042+0.528 * 1.0341+0.404 * 0.7283+0.892 * 0.5677+0.115 * 0.8589
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.8478+4.679 * -0.009367-0.327 * 4.8894
=-4.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was kr1.83 Mil.
Revenue was 1.536 + 1.674 + 2.617 + 1.605 = kr7.43 Mil.
Gross Profit was 1.206 + 1.423 + 2.202 + 1.294 = kr6.13 Mil.
Total Current Assets was kr20.00 Mil.
Total Assets was kr20.18 Mil.
Property, Plant and Equipment(Net PPE) was kr0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was kr0.02 Mil.
Selling, General, & Admin. Expense(SGA) was kr12.49 Mil.
Total Current Liabilities was kr1.47 Mil.
Long-Term Debt & Capital Lease Obligation was kr5.30 Mil.
Net Income was -3.596 + -3.315 + -2.128 + -3.711 = kr-12.75 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0.00 Mil.
Cash Flow from Operations was -3.798 + -3.421 + -2.131 + -3.211 = kr-12.56 Mil.
Total Receivables was kr2.30 Mil.
Revenue was 1.091 + 4.147 + 3.786 + 4.068 = kr13.09 Mil.
Gross Profit was 0.886 + 3.503 + 3.365 + 3.404 = kr11.16 Mil.
Total Current Assets was kr13.92 Mil.
Total Assets was kr14.11 Mil.
Property, Plant and Equipment(Net PPE) was kr0.02 Mil.
Depreciation, Depletion and Amortization(DDA) was kr0.14 Mil.
Selling, General, & Admin. Expense(SGA) was kr11.91 Mil.
Total Current Liabilities was kr0.97 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1.831 / 7.432) / (2.297 / 13.092)
=0.246367 / 0.175451
=1.4042

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(11.158 / 13.092) / (6.125 / 7.432)
=0.852276 / 0.824139
=1.0341

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (20 + 0) / 20.177) / (1 - (13.921 + 0.023) / 14.114)
=0.008772 / 0.012045
=0.7283

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=7.432 / 13.092
=0.5677

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.14 / (0.14 + 0.023)) / (0.023 / (0.023 + 0))
=0.858896 / 1
=0.8589

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(12.494 / 7.432) / (11.911 / 13.092)
=1.681109 / 0.909792
=1.8478

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((5.3 + 1.466) / 20.177) / ((0 + 0.968) / 14.114)
=0.335332 / 0.068584
=4.8894

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-12.75 - 0 - -12.561) / 20.177
=-0.009367

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

ViroGates A/S has a M-score of -4.06 suggests that the company is unlikely to be a manipulator.


ViroGates A/S Beneish M-Score Related Terms

Thank you for viewing the detailed overview of ViroGates A/S's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


ViroGates A/S (OCSE:VIRO) Business Description

Traded in Other Exchanges
N/A
Address
Banevaenget 13, Birkerod, DNK, DK-3460
ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates A/S (OCSE:VIRO) Headlines

No Headlines